AstraZeneca has begun a worldwide recall of its Covid-19 vaccine due to a “surplus of available updated vaccines” that target new variants of the virus. 'The Guardian' reports this, noting that the announcement follows the pharmaceutical company's decision in March to voluntarily withdraw the marketing authorization in the European Union, i.e. the approval for the marketing of a medicine in the member states.
Yesterday the European Medicines Agency issued a warning that the vaccine is no longer authorized for use. In a statement, 'The Guardian' recalls, AstraZeneca said that the decision was made because a variety of newer vaccines are now available that have been adapted to target Covid-19 variants. This had led to a drop in demand for the AstraZeneca vaccine, which is no longer produced or supplied.
The Anglo-Swedish company at the end of April admitted for the first time in court documents during legal proceedings in London that its Covid vaccine can cause thrombosis as a rare side effect. The admission could pave the way for multimillion-dollar settlements, according to British media.